River Global Investors LLP Has $1.42 Million Stock Position in Stericycle, Inc. (NASDAQ:SRCL)

River Global Investors LLP lessened its stake in Stericycle, Inc. (NASDAQ:SRCL) by 0.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 28,619 shares of the business services provider’s stock after selling 245 shares during the quarter. River Global Investors LLP’s holdings in Stericycle were worth $1,419,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in SRCL. Ramirez Asset Management Inc. bought a new position in Stericycle during the third quarter worth about $45,000. Exchange Traded Concepts LLC boosted its stake in shares of Stericycle by 87.5% during the 3rd quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider’s stock worth $45,000 after acquiring an additional 467 shares during the period. Essex Investment Management Co. LLC increased its holdings in shares of Stericycle by 16.8% during the 3rd quarter. Essex Investment Management Co. LLC now owns 2,691 shares of the business services provider’s stock worth $120,000 after acquiring an additional 387 shares during the last quarter. Blue Trust Inc. raised its stake in Stericycle by 15.4% in the 4th quarter. Blue Trust Inc. now owns 3,125 shares of the business services provider’s stock valued at $155,000 after acquiring an additional 416 shares during the period. Finally, Simplicity Solutions LLC acquired a new stake in Stericycle during the 3rd quarter valued at $221,000. 98.82% of the stock is owned by institutional investors.

Stericycle Stock Performance

Shares of NASDAQ:SRCL traded up $1.38 on Friday, reaching $46.18. 423,599 shares of the company’s stock were exchanged, compared to its average volume of 506,754. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $57.06. The company has a fifty day moving average of $50.91 and a 200-day moving average of $48.28. The company has a market capitalization of $4.29 billion, a price-to-earnings ratio of -209.91, a PEG ratio of 2.49 and a beta of 1.12. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. The business had revenue of $664.90 million for the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The firm’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.49 earnings per share. On average, research analysts predict that Stericycle, Inc. will post 2.32 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Truist Financial decreased their price objective on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating on the stock in a report on Monday, April 29th. Stifel Nicolaus upped their price target on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Wells Fargo & Company increased their price target on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a report on Friday, March 1st. StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a research report on Thursday, March 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Stericycle currently has a consensus rating of “Hold” and a consensus target price of $59.40.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.